All news

29 SEPT 2025

Spineway celebrates 20 years of innovation in spine surgery

The Spineway Group, a specialist in innovative implants and instruments for the treatment of severe spine disorders, is celebrating its 20th anniversary this year. Throughout its history, the company has demonstrated an unwavering commitment to innovation and offering surgeons more effective technologies to improve quality of life for patients in France and around the world.

Press releases
30 JULY 2025

H1 2025 results

Continued improvement in results and financial position / Full-year 2025 growth target confirmed

Press releases
25 JULY 2025

Spineway strengthens its international presence with an extensive training program

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, conducted numerous training sessions for surgeons around the world during the first half of 2025. In line with its strategy of international expansion and expertise sharing, the Group organized training courses in Europe, Latin America and Asia, supporting the launch of its product ranges in new markets and consolidating its network of spine surgery professionals.

Press releases
03 JULY 2025

GMED approval for new production line dedicated to ESP prosthèses / First production of LP-ESP intervertebral disc prostheses

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received GMED (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses. This approval is a significant strategic milestone for the Group, ensuring the manufacturing and supply of its innovative ESP prostheses.

Press releases
06 JUN 2025

Minutes of the General Meeting of June 4, 2025

The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Wednesday, June 4, 2025 at 2:00 p.m at the company’s registered office, 7 allée Moulin Berger in Ecully (69).

Press releases
19 MAY 2025

Combined General Meeting of June 4, 2025 Availability of preparatory documents

Spineway informs its shareholders that they are invited to attend the Combined General Meeting to be held on Wednesday, June 4, 2025 at 2:00 p.m. at the Group's headquarters, 7 allée Moulin Berger in Ecully (69).

Press releases
16 APR 2025

First-quarter 2025 revenue of €2.8 million

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.8 million in the first quarter of 2025, stable compared with the fourth quarter of 2024 and down 8% on the revenue for the first quarter of 2024, which constitutes a high comparison base.

Press releases
24 MAR 2025

Consolidated 2024 annual results

• Annual revenue of €12 million (+14%) • Operating income close to breakeven • Reduction in net loss

Press releases
21 MAR 2025

Point sur la procédure judiciaire contre Strategos

Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), annonce que la Cour d’appel du Deleware (United States Court of Appeals for the third circuit) a décidé, dans un jugement rendu le 19 mars 2025, de confirmer la décision rendue en première instance et déboutant le groupe Spineway de sa demande d’exécution de la sentence arbitrale rendue à Genève qui faisait droit à la demande au fond de Spineway.

Press releases
LOADING